专任教师—许晓玥

许晓玥

博士，研究方向为固体制剂与纳米制剂。曾获国家留学基金委资助，赴丹麦哥本哈根大学药学系攻读并取得博士学位。在无定形药物、纳米眼用胶束、固态表征及固体制剂开发等领域具备扎实的科研积累与实践经验。曾就职于大型国际制药企业，以核心成员身份参与多项创新药与仿制药的研发项目。目前以第一/共一作者在SCI期刊发表论文8篇。

1. mail:xuxiaoyue_sally@126.com

   个人主页或网站：

   教育经历

   2020年12月—2024年8月 哥本哈根大学，博士

   2016年9月—2019年6月 中国药科大学，硕士

   2012年9月—2016年6月 中国药科大学，学士

   代表性科研、教改项目

   代表性论著

   [1]Xu, X.; Grohganz, H.; Knapik-Kowalczuk, J.; Paluch, M.; Rades, T., Mechanistic investigation into crystallization of hydrated co-amorphous systems of flurbiprofen and lidocaine,Pharmaceutics, Vol. 17, No. 2, pp. 175, Jan., 2025.

   [2]Xu, X.; Grohganz, H.; Rades, T., Anti-plasticizing effect of water on prilocaine and lidocaine – the role of the hydrogen bonding pattern,Phys. Chem. Chem. Phys., Vol. 26, pp. 14149-14159, May, 2024.

   [3]Xu, X.; Rades, T.; Grohganz, H., Molecular interactions of hydrated co-amorphous systems of prilocaine and lidocaine,Int. J. Pharm., Vol. 651, pp. 123807, Jan., 2024.

   [4]Xu, X.; Rades, T.; Grohganz, H., Thermal investigation on hydrated co-amorphous systems of nicotinamide and prilocaine,Eur. J. Pharm. Biopharm., Vol. 186, pp. 1-6, Mar., 2023.

   [5]Xu, X.; Grohganz, H.; Rades, T., Influence of water on amorphous lidocaine,Mol. Pharm., Vol. 19, No. 9, pp. 3199-3205, Sep., 2022.

   [6]Xu, X.; Sun, L.; Cheng, Y.; Cao, F., Functional chitosan oligosaccharide nanomicelles for topical ocular drug delivery of dexamethasone,Carbohydr. Polym., Vol. 227, pp. 115356, Jan., 2020.

   [7] Xu, T.;Xu, X. (co-first author); Cao, F., Functional intercalated nanocomposites with chitosan-glutathione-glycylsarcosine and layered double hydroxides for topical ocular drug delivery,Int. J. Nanomedicine, Vol. 13, pp. 917-937, July, 2018.

   [8] Wang, Y.;Xu, X. (co-first author); Gu, Y.; Cheng, Y.; Cao, F., Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye,Expert Opin. Drug Deliv., Vol. 15, No. 7, pp. 687-701, Feb., 2018.